$EXEL
EXELIXIS, INC. Stock $exel

$exel Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000093976713000017 Filed on May 07, 2013

Income Statement

Concept	2013 Q2	2013 Q1	2012 Q1
Revenue	$11.86M	$9.669M	$18.51M
YoY Change	51.75%	-47.76%	-48.43%
Cost Of Revenue	$285.0K	$280.0K	$0.00
YoY Change
Gross Profit	$11.57M	$9.389M	$18.51M
YoY Change	48.1%	-49.28%
Gross Profit Margin	97.6%	97.1%	100.0%
Selling, General & Admin	$13.18M	$10.55M	$7.900M
YoY Change	93.82%	33.48%	-14.13%
% of Gross Profit	113.91%	112.31%	42.68%
Research & Development	$49.08M	$32.74M	$33.10M
YoY Change	50.5%	-1.09%	-27.58%
% of Gross Profit	424.14%	348.65%	178.8%
Depreciation & Amortization	$800.0K	$842.0K	$1.233M
YoY Change	-42.86%	-31.71%	-35.11%
% of Gross Profit	6.91%	8.97%	6.66%
Operating Expenses	$63.15M	$43.68M	$40.81M
YoY Change	55.79%	7.04%	-25.54%
Operating Profit	-$51.30M	-$34.01M	-$22.30M
YoY Change	56.76%	52.54%
Interest Expense	$11.24M	$11.06M	$4.004M
YoY Change	174.66%	176.15%	-205.37%
% of Operating Profit
Other Income/Expense, Net	-$10.87M	-$10.72M	-$3.844M
YoY Change	189.61%	178.85%
Pretax Income	-$62.16M	-$44.73M	-$26.14M
YoY Change	70.42%	71.11%	-4.95%
Income Tax	$0.00	$0.00	$11.00K
% Of Pretax Income
Net Earnings	-$62.16M	-$44.73M	-$26.15M
YoY Change	70.36%	71.04%	-4.87%
Net Earnings / Revenue	-524.3%	-462.6%	-141.28%
Basic Earnings Per Share
Diluted Earnings Per Share	-$338.0K	-$243.3K	-$184.6K
COMMON SHARES
Basic Shares Outstanding	183.8M shares	183.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q2	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$352.0M	$356.6M	$243.4M
YoY Change	70.05%	46.51%	-19.32%
Cash & Equivalents	$131.8M	$171.2M	$70.47M
Short-Term Investments	$220.2M	$185.3M	$173.0M
Other Short-Term Assets	$18.10M	$23.20M	$4.600M
YoY Change	302.22%	404.35%	-72.62%
Inventory	$681.0K	$280.0K
Prepaid Expenses
Receivables	$4.200M	$3.900M	$1.900M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$375.0M	$383.9M	$250.0M
YoY Change	75.36%	53.58%	-22.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.650M	$5.786M	$7.300M
YoY Change	-12.25%	-20.74%	-46.32%
Goodwill	$63.68M	$63.68M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments	$138.1M	$176.1M	$84.50M
YoY Change	64.99%	108.4%	-1.52%
Other Assets	$7.713M	$8.125M	$7.100M
YoY Change	175.76%	14.44%	-15.48%
Total Long-Term Assets	$237.1M	$275.6M	$162.6M
YoY Change	47.59%	69.48%	-5.19%
TOTAL ASSETS
Total Short-Term Assets	$375.0M	$383.9M	$250.0M
Total Long-Term Assets	$237.1M	$275.6M	$162.6M
Total Assets	$612.1M	$659.5M	$412.6M
YoY Change	63.45%	59.85%	-16.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.458M	$3.498M	$1.900M
YoY Change	17.98%	84.11%	-34.48%
Accrued Expenses	$29.41M	$21.26M	$36.40M
YoY Change	22.62%	-41.59%	-33.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$12.55M	$12.86M	$14.00M
YoY Change	-4.95%	-8.16%	-62.16%
Total Short-Term Liabilities	$74.60M	$67.80M	$87.50M
YoY Change	-17.25%	-22.52%	-55.83%
LONG-TERM LIABILITIES
Long-Term Debt	$323.6M	$318.0M	$168.0M
YoY Change	90.91%	89.28%	-1.81%
Other Long-Term Liabilities	$5.882M	$6.113M	$24.70M
YoY Change	-22.18%	-75.25%	-87.35%
Total Long-Term Liabilities	$329.5M	$324.1M	$192.7M
YoY Change	4259.26%	68.19%	-47.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$74.60M	$67.80M	$87.50M
Total Long-Term Liabilities	$329.5M	$324.1M	$192.7M
Total Liabilities	$415.8M	$404.7M	$280.3M
YoY Change	50.94%	44.37%	-50.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.361B	-$1.299B
YoY Change	16.42%
Common Stock	$184.0K	$184.0K
YoY Change	23.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$196.3M	$254.9M	$132.3M
YoY Change
Total Liabilities & Shareholders Equity	$612.1M	$659.5M	$412.6M
YoY Change	63.45%	59.85%	-16.76%

Cashflow Statement

Concept	2013 Q2	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	-$62.16M	-$44.73M	-$26.15M
YoY Change	70.36%	71.04%	-4.87%
Depreciation, Depletion And Amortization	$800.0K	$842.0K	$1.233M
YoY Change	-42.86%	-31.71%	-35.11%
Cash From Operating Activities	-$40.00M	-$54.42M	-$14.97M
YoY Change	12.99%	263.59%	-65.44%
INVESTING ACTIVITIES
Capital Expenditures	-$700.0K	$729.0K	$72.00K
YoY Change	75.0%	912.5%	-118.0%
Acquisitions
YoY Change
Other Investing Activities	$1.100M	$67.10M	-$52.20M
YoY Change	-96.77%	-228.54%	67.85%
Cash From Investing Activities	$400.0K	$66.35M	-$52.28M
YoY Change	-98.81%	-226.92%	65.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$65.00M
YoY Change		-100.0%	-63.77%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	100.0K	-$10.78M	$63.45M
YoY Change	-116.67%	-116.98%	-64.63%
NET CHANGE
Cash From Operating Activities	-40.00M	-$54.42M	-$14.97M
Cash From Investing Activities	400.0K	$66.35M	-$52.28M
Cash From Financing Activities	100.0K	-$10.78M	$63.45M
Net Change In Cash	-39.50M	$1.163M	-$3.791M
YoY Change	1617.39%	-130.68%	-103.62%
FREE CASH FLOW
Cash From Operating Activities	-$40.00M	-$54.42M	-$14.97M
Capital Expenditures	-$700.0K	$729.0K	$72.00K
Free Cash Flow	-$39.30M	-$55.14M	-$15.04M
YoY Change	12.29%	266.7%	-64.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3498000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4398000	USD
CY2012Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	10375000	USD
CY2013Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	6500000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20560000	USD
CY2013Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21263000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-92000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	102000	USD
CY2013Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1553297000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1550345000	USD
CY2012Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2304000	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2675000	USD
CY2013Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6314000	USD
CY2012Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2193000	USD
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19823000	shares
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	73745000	shares
CY2013Q1	us-gaap	Assets Assets	659527000	USD
CY2012Q4	us-gaap	Assets Assets	721097000	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	383945000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	432541000	USD
CY2013Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	566692000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	634053000	USD
CY2013Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	174000000	USD
CY2013Q1	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	566757000	USD
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	633961000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	149000	USD
CY2012Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	191000	USD
CY2013Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	214000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	99000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	170069000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	171232000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	70466000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74257000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3791000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1163000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	183697213	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	183789132	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	183789132	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	183697213	shares
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	183000	USD
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	184000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25963000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-44535000	USD
CY2012Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	10000000	USD
CY2013Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	10000000	USD
CY2013Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	236385000	USD
CY2012Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	240476000	USD
CY2013Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	280000	USD
CY2012Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
CY2013Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	9211000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	16321000	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	842000	USD
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1233000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2013Q1	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exelixis adopted a 52- or 53-week fiscal year that generally ends on the Friday closest to December 31</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">st</sup></font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7905000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10545000	USD
CY2013Q1	us-gaap	Goodwill Goodwill	63684000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	63684000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-44729000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-26140000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5472000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2736000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-7110000	USD
CY2012Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-18480000	USD
CY2012Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	280000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	116000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-87000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-143000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-27870000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1114000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4757000	USD
CY2012Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	268000	USD
CY2012Q1	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-504000	USD
CY2012Q1	us-gaap	Interest Expense InterestExpense	4004000	USD
CY2013Q1	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-6647000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	11057000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	13170000	USD
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	USD
CY2013Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	55000	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	280000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	0	USD
CY2013Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	93000	USD
CY2012Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	0	USD
CY2013Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	132000	USD
CY2012Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	0	USD
CY2012Q4	us-gaap	Liabilities Liabilities	424663000	USD
CY2013Q1	us-gaap	Liabilities Liabilities	404675000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	721097000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	659527000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	67799000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	81704000	USD
CY2013Q1	us-gaap	Long Term Debt LongTermDebt	330854000	USD
CY2012Q4	us-gaap	Long Term Debt LongTermDebt	335736000	USD
CY2013Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	12858000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	322566000	USD
CY2013Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	317996000	USD
CY2012Q4	us-gaap	Long Term Investments LongTermInvestments	182311000	USD
CY2013Q1	us-gaap	Long Term Investments LongTermInvestments	176088000	USD
CY2012Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	82090000	USD
CY2013Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	81611000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	63453000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10775000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	66353000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-52278000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14966000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54415000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-44729000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-26151000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10719000	USD
CY2012Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3844000	USD
CY2012Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3170000	USD
CY2013Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2858000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	40806000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	43679000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-34010000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-22296000	USD
CY2013Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10392000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11795000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8538000	USD
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8125000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	188000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	194000	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6113000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6256000	USD
CY2012Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1304000	USD
CY2013Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1733000	USD
CY2012Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	160000	USD
CY2013Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	338000	USD
CY2013Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	96157000	USD
CY2012Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	113368000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	72000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	729000	USD
CY2012Q1	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	504000	USD
CY2013Q1	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	504000	USD
CY2013Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6104000	USD
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11030000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	64990000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2013Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-10791000	USD
CY2012Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-1646000	USD
CY2012Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	60315000	USD
CY2013Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	157096000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2012Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	847000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6059000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5786000	USD
CY2013Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	3865000	USD
CY2012Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	2751000	USD
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33096000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32735000	USD
CY2013Q1	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	12206000	USD
CY2012Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	12246000	USD
CY2013Q1	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	21899000	USD
CY2012Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	27964000	USD
CY2013Q1	us-gaap	Restructuring And Related Cost Expected Cost RestructuringAndRelatedCostExpectedCost	2500000	USD
CY2013Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Inception To Date RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate	422	employee
CY2013Q1	us-gaap	Restructuring Charges RestructuringCharges	119000	USD
CY2012Q1	us-gaap	Restructuring Charges RestructuringCharges	-195000	USD
CY2013Q1	us-gaap	Restructuring Costs RestructuringCosts	-2378000	USD
CY2012Q1	us-gaap	Restructuring Costs RestructuringCosts	-1865000	USD
CY2012Q1	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	-195000	USD
CY2013Q1	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	0	USD
CY2013Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	4077000	USD
CY2012Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	5085000	USD
CY2012Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	14137000	USD
CY2013Q1	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	12767000	USD
	us-gaap	Restructuring Reserve Settled With Cash RestructuringReserveSettledWithCash	31200000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1298731000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1254002000	USD
CY2013Q1	us-gaap	Revenues Revenues	9669000	USD
CY2012Q1	us-gaap	Revenues Revenues	18510000	USD
CY2013Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1856000	USD
CY2012Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	0	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2679000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2332000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12886469	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.35
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	551876	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	284610	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	167000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18448550	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18177718	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.85
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.83
CY2013Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.42
CY2013Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.38
CY2013Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.64
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	140000	USD
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M21D
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M7D
CY2012Q4	us-gaap	Short Term Investments ShortTermInvestments	241371000	USD
CY2013Q1	us-gaap	Short Term Investments ShortTermInvestments	185332000	USD
CY2013Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3566	shares
CY2013Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	254852000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	296434000	USD
CY2013Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the consolidated financial statements is in conformity with accounting principles generally accepted in the United States which requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates including, but not limited to, those related to revenue recognition, inventory valuation, valuation of long-lived assets, certain accrued liabilities, share-based compensation and the valuation of the debt and equity components of our convertible debt at issuance. We base our estimates on historical experience and on various other market-specific and other relevant assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.</font></div></div>
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	183742000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	141940000	shares
CY2012	exel	Annual Operating Cycle AnnualOperatingCycle	P52W
CY2013Q1	exel	Available For Sale Securities Unrealized Loss Position Term AvailableForSaleSecuritiesUnrealizedLossPositionTerm	P1Y
CY2013Q1	exel	License And Contracts Revenue LicenseAndContractsRevenue	7813000	USD
CY2012Q1	exel	License And Contracts Revenue LicenseAndContractsRevenue	18510000	USD
CY2013Q1	exel	Proceeds From Exercise Of Stock Options And Warrants Net Of Repurchases ProceedsFromExerciseOfStockOptionsAndWarrantsNetOfRepurchases	16000	USD
CY2012Q1	exel	Proceeds From Exercise Of Stock Options And Warrants Net Of Repurchases ProceedsFromExerciseOfStockOptionsAndWarrantsNetOfRepurchases	109000	USD
CY2013Q1	exel	Sales Revenue Percent Discount For Prompt Payment SalesRevenuePercentDiscountForPromptPayment	0.02
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-28
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-29
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000939767
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	183801796	shares
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	EXELIXIS, INC.
CY2013Q1	dei	Trading Symbol TradingSymbol	exel

Files In Submission

Name	View Source	Status
0000939767-13-000017-index-headers.html	Edgar Link	pending
0000939767-13-000017-index.html	Edgar Link	pending
0000939767-13-000017.txt	Edgar Link	pending
0000939767-13-000017-xbrl.zip	Edgar Link	pending
exel-20130329.xml	Edgar Link	completed
exel-20130329.xsd	Edgar Link	pending
exel-20130329_cal.xml	Edgar Link	unprocessable
exel-20130329_def.xml	Edgar Link	unprocessable
exel-20130329_lab.xml	Edgar Link	unprocessable
exel-20130329_pre.xml	Edgar Link	unprocessable
exel2013033110-q.htm	Edgar Link	pending
exel20130331exhibit311.htm	Edgar Link	pending
exel20130331exhibit312.htm	Edgar Link	pending
exel20130331exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXEL
EXELIXIS, INC. Stock $exel

2013 Q2 Form 10-Q Financial Statement

#000093976713000017 Filed on May 07, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXEL EXELIXIS, INC. Stock $exel

2013 Q2 Form 10-Q Financial Statement

#000093976713000017 Filed on May 07, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXEL
EXELIXIS, INC. Stock $exel